Summary Stage 2018: Parathyroid
Summary Stage 2018
Notes
**Parathyroid**
8000-8700, 8720-8790, 8940-8960, 8965-8983, 9000, 9050-9111, 9270, 9300-9312, 9340-9363, 9380-9539, 9541
C750: Parathyroid
**Note 1:** **Sources used in the development of this chapter**
* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)
* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/)
* Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx
* Chapter 75 *Parathyroid*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.
**Note 2:** **Other Summary Stage Chapters with Parathyroid sites**
* **GIST**: 8935-8936
* **Kaposi Sarcoma**: 9140
* **Mycosis Fungoides**: 9700-9701
* **Soft Tissue**: 8710-8714, 8800-8934, 8963-8964, 8990-8992, 9010-9045, 9120-9138, 9141-9262, 9271-9290, 9320-9330, 9364-9373, 9540, 9542-9582
**Note 3:** **Definition of parathyroid tumors**
* Parathyroid tumors are defined as left or right and superior (upper) or inferior (lower).
**Note 4:** **Atypical parathyroid neoplasms**
* Atypical parathyroid neoplasms (code 0) are defined as tumors that are histologically or clinically worrisome but do not fulfill the more robust criteria [i.e., invasion metastasis] for carcinoma.
**Note 5:** **Location of metastases**
* Metastases for the parathyroid is anything beyond the central and lateral part of the neck.
| SS2018 |
Description |
| 0 |
**In situ, intraepithelial, noninvasive**
* Atypical parathyroid neoplasm (neoplasm of uncertain malignant potential) |
| 1 |
**Localized only (localized, NOS)**
* Confined to parathyroid
* Extension to soft tissue |
| 2 |
**Regional by direct extension only**
* Adjacent lymph nodes
* Esophagus
* Recurrent laryngeal nerve
* Thymus
* Thyroid gland
* Trachea
* Skeletal muscle |
| 3 |
**Regional lymph node(s) involved only**
* Level I
- Level IA - Submental
- Level IB - Submandibular
* Level II - Upper jugular
- Jugulodigastric (subdigastric)
- Upper deep cervical
- Level IIA - Anterior
- Level IIB - Posterior
* Level III - Middle jugular
- Middle deep cervical
* **Level IV - Lower jugular**
- Jugulo-omohyoid (supraomohyoid)
- Lower deep cervical
- Virchow node
* Level V - Posterior triangle group
- Posterior cervical
- Level VA - Spinal accessory
- Level VB - Transverse cervical, supraclavicular
* Level VI - Anterior compartment group
- Laterotracheal
- Paralaryngeal
- Paratracheal - above suprasternal notch
- Perithyroidal
- Precricoid (Delphian)
- Prelaryngeal
- Pretracheal - above suprasternal notch
- Recurrent laryngeal
* Level VII - Superior mediastinal group (for other mediastinal node(s) see code 7)
- Esophageal groove
- Paratracheal - below suprasternal notch
- Pretracheal - below suprasternal notch
* Other lymph nodes
- Cervical, NOS
- Deep cervical, NOS
- Facial
+ Buccinator (buccal)
+ Mandibular
+ Nasolabial
- Internal jugular, NOS
- Parapharyngeal
- Parotid
+ Infraauricular
+ Intraparotid
+ Periparotid
+ Preauricular
- Retroauricular (mastoid)
- Retropharyngeal
- Suboccipital
* Regional lymph node(s), NOS
- Lymph node(s), NOS |
| 4 |
**Regional by BOTH direct extension AND regional lymph node(s) involved**
* Codes (2) + (3) |
| 7 |
**Distant site(s)/lymph node(s) involved**
* Distant site(s) (including further contiguous extension)
- Bone
- Diaphragm
- Liver
- Lung
- Pancreas
- Spleen
* Distant lymph node(s), NOS
* Distant metastasis, NOS
- Carcinomatosis
- Distant metastasis WITH or WITHOUT distant lymph node(s) |
| 9 |
Unknown if extension or metastasis |
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998
(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.
(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)
(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017
(5) Kakar, S., Pawlik, T.M., Vauthey, J.N., et al. **Exocrine Pancreas**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017
